ALLO

Allogene Therapeutics Inc

Jun 05 • 04:00PM ET

1.88

-0.16 -7.84 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN RYTM KYMR INCY NUVL VKTX AXSM NBIX

| Held by: VTI XBI IWM VXF IBB IWN FESM SCHA DFAS VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	25.61%	Shs Outstand	345.15M	Perf Week	-13.36%
Market Cap	648.89M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.32%	Shs Float	256.74M	Perf Month	-18.61%
Enterprise Value	463.05M	PEG	-	EPS next Q	-0.17	Inst Own	39.27%	Short Float	16.47%	Perf Quarter	-18.26%
Income	-173.76M	P/S	-	EPS this Y	17.78%	Inst Trans	7.15%	Short Ratio	4.34	Perf Half Y	23.68%
Sales	0.00M	P/B	1.65	EPS next Y	-12.38%	ROA	-38.45%	Short Interest	42.28M	Perf YTD	37.23%
Book/sh	1.14	P/C	2.43	EPS next 5Y	6.15%	ROE	-52.32%	52W High	4.46 -57.85%	Perf Year	45.74%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 91.02%	Perf 3Y	-66.25%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.33% 6.55%	Perf 5Y	-92.10%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.16	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	37.76	Recom	1.36
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	-10.33%	Beta	0.46	Target Price	8.35
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-17.36%	Rel Volume	0.82	Prev Close	2.04
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	9.04%	Avg Volume	9.74M	Price	1.88
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	7,950,146	Change	-7.84%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)